Veracyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.About VCYT
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.
CEOMarc A. Stapley
CEOMarc A. Stapley
Employees815
Employees815
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2006
Founded2006
Employees815
Employees815
VCYT Key Statistics
Market cap1.47B
Market cap1.47B
Price-Earnings ratio-19.06
Price-Earnings ratio-19.06
Dividend yield—
Dividend yield—
Average volume727.99K
Average volume727.99K
High today$19.77
High today$19.77
Low today$19.19
Low today$19.19
Open price$19.55
Open price$19.55
Volume226.78K
Volume226.78K
52 Week high$30.52
52 Week high$30.52
52 Week low$18.61
52 Week low$18.61
VCYT News
Simply Wall St 1d
Even after rising 3.6% this past week, Veracyte shareholders are still down 59% over the past three ... - Simply Wall StIf you love investing in stocks you're bound to buy some losers. Long term Veracyte, Inc. ( ) shareholders know that all too well, since the share price is down...
TipRanks 4d
Veracyte study shows Decipher Prostate Test is prognosticVeracyte announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance AS for prostate cancer, the De...
Analyst ratings
67%
of 9 ratingsBuy
66.7%
Hold
22.2%
Sell
11.1%